Micro- and Nanofluidic Tools to Understand Biology and Personalize Care
Official title: Micro and Nanofluidic Technologies for Conveying the Central Dogma in Biology and Precision Medicine
Funded at University of Kansas Lawrence · NIH-11336093 · Data updated 2026-11-12
A center project is developing tiny fluidic tools that help generate multi-omics data to support precision medicine and train researchers in new bioengineering techniques.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project start | September 16, 2015 |
| Project end | March 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $110,274 |
| NIH project number | 2P41EB020594-12 |
| Project ID | NIH-11336093 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients whose care could benefit from improved liquid-biopsy analyses and precision medicine approaches.
✕Less likely to help
Patients whose conditions are not linked to liquid biopsy or precision medicine innovations may see limited direct benefit.
What this research studies
This grant supports a center that creates micro- and nanofluidic technology to analyze small amounts of biological samples, with a focus on translating findings into patient care. It emphasizes training and sharing methods so researchers across disciplines can use these tools for precision medicine. The work combines engineering, biology, and data science to improve molecular analysis of liquid biopsy samples and related workflows. Through hands-on education and dissemination, patients may benefit from faster adoption of advanced diagnostic approaches.
Why it matters
Potential benefit: If successful, these technologies could improve how we analyze patient samples and tailor treatments based on detailed molecular information.
How similar studies have gone: Previous efforts in micro- and nanofluidics have shown promise in enhancing molecular analyses, with ongoing translation to clinical tools.
Where this research is happening
-
University of Kansas Lawrence
Lawrence, United States Active
Researchers
- Principal investigator: Witek, Malgorzata Anna — University of Kansas Lawrence
- Study coordinator: Witek, Malgorzata Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.